Pharmacology

Unit I: Introduction to Pharmacology

1. Drug Action: Pharmaceutic, Pharmacokinetic, and Pharmacodynamic Phases

2. The Drug Approval Process

3. Cultural and Pharmacogenetic Considerations

4. Drug Interactions and Over-the-Counter Drugs

5. Drugs of Abuse

6. Herbal Therapies

7. Pediatric Pharmacology

8. Geriatric Pharmacology

9. Collaboration in Community Settings NEW QSEN focus!

10. The Role of the Nurse in Drug Research
Unit II: A Nurse’s Perspective of Pharmacology

11. The Nursing Process in Patient-Centered Pharmacotherapy NEW QSEN focus!

12. Safety and Quality in Pharmacotherapy NEW QSEN focus!

13. Medication Administration
Unit III: Drug Calculations

14. Medications and Calculations
Section 14A: Systems of Measurement with Conversion
Section 14B: Methods for Calculation
Section 14C: Calculations of Oral Dosages
Section 14D: Calculations of Injectable Dosages
Section 14E: Calculations of Intravenous Fluids
Section 14F: Pediatric Drug Calculations
Unit IV: Nutrition and Electrolytes

15. Vitamin and Mineral Replacement

16. Fluid and Electrolyte Replacement

17. Nutritional Support
Unit V: Autonomic Nervous System Agents

18. Adrenergic Agonists and Adrenergic Blockers

19. Cholinergic Agonists and Anticholinergics
Unit VI: Neurologic and Neuromuscular Agents

20. Central Nervous System Stimulants

21. Central Nervous System Depressants

22. Anticonvulsants

23. Drugs for Neurological Disorders: Parkinsonism and Alzheimer’s Disease

24. Drugs for Neuromuscular Disorders: Myasthenia Gravis, Multiple Sclerosis, and Muscle Spasms
Unit VII: Pain and Inflammation Management Agents

25. Antiinflammatory Drugs

26. Nonopioid and Opioid Analgesics
Unit VIII: Psychiatric Agents

27. Antipsychotics and Anxiolytics

28. Antidepressants and Mood Stabilizers
Unit IX: Antibacterial and Antiinfective Agents

29. Penicillins and Cephalosporins

30. Macrolides, Tetracyclines, Aminoglycosides, and Fluoroquinolones

31. Sulfonamides
Unit X: Additional Antiinfective Agents

32. Antituberculars, Antifungals, Peptides, and Metronidazole

33. Antivirals, Antimalarials, and Anthelmintics

34. Drugs for Urinary Tract Disorders
Unit XI: Immunologic Agents

35. HIV- and AIDS-Related Drugs

36. Vaccines
Unit XII: Antineoplastic Agents

37. Anticancer Drugs

38. Targeted Therapies to Treat Cancer

39. Biologic Response Modifiers
Unit XIII: Respiratory Agents

40. Drugs for Upper Respiratory Disorders

41. Drugs for Lower Respiratory Disorders
Unit XIV: Cardiovascular Agents

42. Cardiac Glycosides, Antianginals, and Antidysrhythmics

43. Diuretics

44. Antihypertensives

45. Anticoagulants, Antiplatelets, and Thrombolytics

46. Antihyperlipidemics and Peripheral Vasodilators
Unit XV: Gastrointestinal Agents

47. Drugs for Gastrointestinal Tract Disorders

48. Antiulcer Drugs
Unit XVI: Eye, Ear, and Skin Agents

49. Drugs for Eye and Ear Disorders

50. Drugs for Dermatologic Disorders
Unit XVII: Endocrine Agents

51. Endocrine Drugs: Drugs for Pituitary, Thyroid, Parathyroid, and Adrenal Disorders

52. Antidiabetics
Unit XVIII: Reproductive and Gender-Related Agents

53. Female Reproductive Cycle I: Pregnancy and Preterm Labor Drugs

54. Female Reproductive Cycle II: Labor, Delivery, and Preterm Neonatal Drugs

55. Postpartum and Newborn Drugs

56. Drugs for Women’s Reproductive Health and Menopause

57. Drugs for Men’s Health and Reproductive Disorders

58. Drugs for Disorders in Women’s Health, Infertility, and Sexually Transmitted Infections
Unit XIX: Emergency Agents

59. Adult and Pediatric Emergency Drugs
Appendices
A: Therapeutic Drug Monitoring
B: Potential Weapons of Bioterrorism
References